This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Lifshitz & Miller Law Firm Announces Investigation Of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., Peoples Federal Bancshares, Inc. And Siuslaw Financial Group, Inc.

NEW YORK, Aug. 8, 2014 /PRNewswire/ --

Cobalt International Energy, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of Cobalt International Energy, Inc. ("CIE"). Specifically, on August 5, 2014, the Company disclosed that it received an SEC Wells Notice in connection with the company's Angolan operations.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

DreamWorks Animation SKG, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the Central District of California alleging that DreamWorks Animation SKG, Inc. ("DWA") violated federal securities laws between October 29, 2013 and July 29, 2014. On July 29, 2014, the Company disclosed that the SEC is conducting an investigation related to the Company's prior write-down of film inventory for Turbo.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Galectin Therapeutics, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the District of Nevada alleging that Galectin Therapeutics, Inc. (" GALT") violated federal securities laws between January 6, 2014 and July 28, 2014. Specifically, the Complaint alleges that Galectin was paying for misleading promotional campaigns to entice investors to buy its stock.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Impax Laboratories, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of Impax Laboratories, Inc. ("IPXL"). Specifically, on July 29, 2014, the Company disclosed that the Food and Drug Administration uncovered several issues at the Company's Taiwan facility where IPXL manufactures Rytary, an experimental Parkinson's disease drug.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Peoples Federal Bancshares, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Peoples Federal Bancshares, Inc. ("PEOP") to Independent Bank Corp. in a cash and stock transaction valued at approximately $21.00 per share or $130.6 million.

Lifshitz & Miller's investigation is focused on whether the PEOP directors are acting in shareholders best interest.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,074.42 -128.95 -0.71%
S&P 500 2,094.94 -12.84 -0.61%
NASDAQ 4,961.5720 -18.3290 -0.37%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs